P-VABEC

Known as: BLEO/CTX/DOX/PRED/VCR/VP-16, Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine, VACOP-B 
A chemotherapy combination consisting of bleomycin, cyclophosphamide, doxorubicin, etoposide, prednisone and vincristine.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2016
01219912016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BACKGROUND Third-generation regimens (MACOP-B [methotrexate/leucovorin (LV)/doxorubicin/cyclophosphamide/vincristine/ prednisone… (More)
Is this relevant?
2007
2007
PURPOSE The optimal therapy for primary mediastinal large B-cell lymphoma (PMLBCL) remains undefined. The superiority of… (More)
Is this relevant?
2005
2005
BACKGROUND There is not univocal concordance for using high-dose sequential therapy (HDS) as first-line treatment for aggressive… (More)
Is this relevant?
2002
2002
Options for relapsed/refractory indolent lymphoma include chemotherapy, immunotherapy and high-dose therapy with autologous… (More)
Is this relevant?
2002
2002
The aim of our study was to evaluate the impact of an early intensification programme including chemotherapy (CHT), autologous… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2000
2000
BACKGROUND AND OBJECTIVE Sequential treatment with the addition of high-dose therapy (HDT) and peripheral blood progenitor cell… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE The aim of this multicenter randomized study was to compare conventional therapy with conventional plus high-dose therapy… (More)
Is this relevant?
Review
1998
Review
1998
Since the early 1970s, three generations of combination chemotherapy for intermediate-grade non-Hodgkin's lymphomas (NHL) have… (More)
Is this relevant?
1993
1993
PURPOSE To evaluate the clinical features of presentation, the morphologic and immunohistochemical pattern, the modality of… (More)
Is this relevant?
1991
1991
Between 1981 and 1986, 126 patients with diffuse large cell lymphoma were treated with MACOP-B (methotrexate/doxorubicin… (More)
Is this relevant?